ask="1.17"
ask_size="7800"
average_daily_volume="535434"
bid="1.03"
bid_size="5000"
book_value="0.52"
change="-0.01"
change_from_200_day_moving_average="0.05"
change_from_50_day_moving_average="-0.02"
change_from_52_week_high="-0.81"
change_From_52_week_low="0.61"
change_in_percent="-0.88%"
close="1.12"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.24"
ebitda="-20.52M"
eps_estimate_current_year="-0.24"
eps_estimate_next_quarter="-0.07"
eps_estimate_next_year="-0.27"
ex_dividend_date="N/A"
float_shares="56757000"
high="1.14"
high_52_weeks="1.93"
last_trade_date="2/8/2017"
last_trade_price="1.12"
last_trade_size="524"
last_trade_time="4:00pm"
low="1.11"
low_52_weeks="0.51"
market_capitalization="92.81M"
moving_average_200_day="1.07"
moving_average_50_day="1.14"
name="Catalyst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="4.38"
open="1.14"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+4.32%"
percent_change_from_50_day_moving_average="-1.73%"
percent_change_from_52_week_high="-42.06%"
percent_change_from_52_week_low="+119.61%"
previous_close="1.13"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.18"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="82870000"
short_ratio="3.88"
stock_exchange="NCM"
symbol="CPRX"
volume="123344"
weeks_range_52="0.51 - 1.93"
